Safety of monoclonal antibodies for the treatment of multiple sclerosis
- 期刊名称Expert Opinion on Drug Safety
- 作者McGinley, Marisa P; Moss, Brandon P; Cohen, Jeffrey A
- 印刷ISSN1474-0338
- 电子ISSN1744-764X
- 文件大小724.52KB
- 发表时间2016-10-19
- DOI10.1080/14740338.2017.1250881
Purified endogenous inhibitor of the Na/Ca exchanger can enhance the cardiomyocytes contractility and calcium transientsBoyman Liron; Hiller Reuben; Shpak Beni; Shpak Chagit; Daniel Khananshvili · 2006
Advanced procedures for separation and analysis of low molecular weight inhibitor (NCXIF) of the cardiac sodium–calcium exchangerLiron Boyman; Reuben Hiller; Beni Shpak; Erika Yomtov; Chagit Shpak; Daniel Khananshvili · 2005
Inotropic and Lusitropic Effects Induced by the Inhibitory Factor of the Na/Ca Exchanger Are Not Mediated by the β-Adrenergic ActivationShpak, Beni; Shpak, Chagit; Hiller, Reuben; Boyman, Liron; Khananshvili, Daniel · Journal of Cardiovascular Pharmacology · 2004
Effects of purified endogenous inhibitor of the Na+/Ca2+ exchanger on ouabain-induced arrhythmias in the atria and ventricle strips of guinea pigBeni Shpak; Yana Gofman; Chagit Shpak; Reuben Hiller; Liron Boyman; Daniel Khananshvili · 2006
The low molecular weight inhibitor of NCX1 interacts with a cytosolic domain that differs from the ion-transport site of the Na/Ca exchangerChagit Shpak; Reuben Hiller; Beni Shpak; Liron Boyman; Daniel Khananshvili · 2004